corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 20467

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Durand de Bousingen D
Growth-hormone CJD scandal rocks France
The Lancet 1997 Jan 18; 349:(9046):189
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2805%2960939-7/fulltext#article_upsell


Abstract:

Despite a total ban on the therapeutic use of growth hormone from human cadavers in June, 1985, the Central Pharmacy of the Paris Hospital Union continued to deliver 20 000 ampoules of the product until February, 1986, to avoid the losses that would have resulted from the destruction of the FFr5·5-million stock. The story was revealed by the weekly magazine ľExpress on Jan 9, but has subsequently been confirmend by Marie-Odile Bertella Geffroy, the judge who has presided over investigations into u …

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.